Business News Agency reported on September 6th last week that at the seminar organized by the Guangdong Province Food and Drug Administration, Yang Wei, a professional drug inspector specializing in drug registration in China, introduced that in the past five years, China's drug registration report has dropped by 675%. The registration policy will be further in line with international standards. The approval of new drugs will be linked to the creation of a major national new drug and the rapid launch of truly innovative drugs will be realized.